News

Young patients with advanced Hodgkin's lymphoma, a cancer of the lymphatic system, now have a better chance of having their own children after treatment.
The Medicines and Healthcare products Regulatory Agency (MHRA) has cleared the oral neurokinin (NK) 1 and 3 antagonist, under the Lynkuet brand name, for the treatment of moderate to severe vasomotor ...
A groundbreaking study by the National Institutes of Health (NIH) is shifting the conversation around hormone therapy and ...
Associations between hormone therapy and young-onset breast cancer (diagnosed at younger than 55 years) vary, according to a ...
Young patients with advanced Hodgkin's lymphoma, a cancer of the lymphatic system, now have a better chance of having their ...
Young patients with advanced Hodgkin's lymphoma, a cancer of the lymphatic system, now have a better chance of having their ...
Menopausal hormonal therapy, including estrogen alone and estrogen combined with progesterone, has been prescribed to help with those symptoms for decades. Hormones were also used to treat the ...
Menopause causes a range of symptoms. Some supplements may help. Learn which menopause supplements can help ease symptoms.
Data from clinical trials have indicated that PSA is prognostic for outcomes, but little is known about real-world trends.
T heir names are unknown but their pain is nonetheless evident. A user on Reddit, a social-media site, was “fairly close to ...
Pfizer (NYSE:PFE) and Astellas Pharma (OTCPK:ALPMF) (OTCPK:ALPMY) announced on Thursday that their jointly developed antitumor agent Xtandi reached its secondary goal as part of a combination therapy ...